abstract
Future of Health Summit 2023

Part 1: A Global Priority: The Fight Against Antimicrobial Resistance

-

Antimicrobial resistance (AMR), rapidly rising worldwide, is now a leading cause of death. Globally, 1.27 million people died as a direct result of AMR in 2019; another 5 million deaths were associated with it. Every year, 48,000 Americans die from antibiotic-resistant infections. In 2023, US public health officials sounded the alarm on an emerging fungus spreading rapidly in health-care facilities, an increase in drug-resistant shigellosis, and the threat of a drug-resistant strain of gonorrhea. The UN plans a high-level meeting in 2024 to address the global menace of AMR. But while conversations around AMR focus on possible solutions, such as the need for new antibiotics, the human cost, already high, continues to rise. The experts on this panel will discuss the danger for patients and the toll already taken, and will look toward building support for life-saving solutions.   

    Opening Remarks

    Image

    Brian Carandang

    Associate Director, Business and Program Development, Milken Institute

    Moderator

    Image

    Lynn Goldman

    Dean, Milken Institute School of Public Health, George Washington University

    Speakers

    Image

    Gunnar Esiason

    Head of Patient Engagement, RA Ventures
    Image

    Thomas Heymann

    President and CEO, Sepsis Alliance
    Image

    Christine Ann Miller

    President and CEO, Melinta Therapeutics
    Image

    Susan Monarez

    Deputy Director, Advanced Research Projects Agency for Health (ARPA-H)